Logo image of MORLD.OL

MORELD ASA (MORLD.OL) Stock Fundamental Analysis

Europe - OSL:MORLD - NO0013325506 - Common Stock

18 NOK
-0.06 (-0.33%)
Last: 10/6/2025, 7:00:00 PM
Fundamental Rating

2

Overall MORLD gets a fundamental rating of 2 out of 10. We evaluated MORLD against 43 industry peers in the Construction & Engineering industry. Both the profitability and financial health of MORLD have multiple concerns. MORLD has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year MORLD has reported negative net income.
MORLD.OL Yearly Net Income VS EBIT VS OCF VS FCFMORLD.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 0 500M -500M 1B 1.5B

1.2 Ratios

The Return On Assets of MORLD (-11.35%) is worse than 97.67% of its industry peers.
Looking at the Return On Equity, with a value of -81.15%, MORLD is doing worse than 97.67% of the companies in the same industry.
With a decent Return On Invested Capital value of 10.74%, MORLD is doing good in the industry, outperforming 60.47% of the companies in the same industry.
Industry RankSector Rank
ROA -11.35%
ROE -81.15%
ROIC 10.74%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MORLD.OL Yearly ROA, ROE, ROICMORLD.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 0 50 -50 100 -100

1.3 Margins

MORLD has a Operating Margin of 6.38%. This is comparable to the rest of the industry: MORLD outperforms 51.16% of its industry peers.
Looking at the Gross Margin, with a value of 56.69%, MORLD is in the better half of the industry, outperforming 69.77% of the companies in the same industry.
Industry RankSector Rank
OM 6.38%
PM (TTM) N/A
GM 56.69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MORLD.OL Yearly Profit, Operating, Gross MarginsMORLD.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 0 -500 -1K -1.5K -2K -2.5K

More info and screens

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MORLD is creating some value.
Compared to 1 year ago, MORLD has more shares outstanding
Compared to 1 year ago, MORLD has an improved debt to assets ratio.
MORLD.OL Yearly Shares OutstandingMORLD.OL Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 50M 100M 150M
MORLD.OL Yearly Total Debt VS Total AssetsMORLD.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 1.74, we must say that MORLD is in the distress zone and has some risk of bankruptcy.
MORLD has a Altman-Z score (1.74) which is in line with its industry peers.
A Debt/Equity ratio of 2.37 is on the high side and indicates that MORLD has dependencies on debt financing.
The Debt to Equity ratio of MORLD (2.37) is worse than 90.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.37
Debt/FCF N/A
Altman-Z 1.74
ROIC/WACC1.36
WACC7.92%
MORLD.OL Yearly LT Debt VS Equity VS FCFMORLD.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

MORLD has a Current Ratio of 1.00. This is a bad value and indicates that MORLD is not financially healthy enough and could expect problems in meeting its short term obligations.
MORLD has a Current ratio of 1.00. This is in the lower half of the industry: MORLD underperforms 65.12% of its industry peers.
MORLD has a Quick Ratio of 1.00. This is a bad value and indicates that MORLD is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.98, MORLD perfoms like the industry average, outperforming 46.51% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 0.98
MORLD.OL Yearly Current Assets VS Current LiabilitesMORLD.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 1B 2B 3B

More info and screens

4

3. Growth

3.1 Past

MORLD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1075.10%.
The Revenue has grown by 665749.35% in the past year. This is a very strong growth!
EPS 1Y (TTM)-1075.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)665749.35%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, MORLD will show a very strong growth in Earnings Per Share. The EPS will grow by 39.99% on average per year.
MORLD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.57% yearly.
EPS Next Y174.7%
EPS Next 2Y64.89%
EPS Next 3Y39.99%
EPS Next 5YN/A
Revenue Next Year42.2%
Revenue Next 2Y16.33%
Revenue Next 3Y11.57%
Revenue Next 5YN/A

3.3 Evolution

MORLD.OL Yearly Revenue VS EstimatesMORLD.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
MORLD.OL Yearly EPS VS EstimatesMORLD.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 1 2 3

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MORLD. In the last year negative earnings were reported.
MORLD is valuated cheaply with a Price/Forward Earnings ratio of 6.20.
Based on the Price/Forward Earnings ratio, MORLD is valued cheaper than 95.35% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.36, MORLD is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 6.2
MORLD.OL Price Earnings VS Forward Price EarningsMORLD.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MORLD indicates a rather cheap valuation: MORLD is cheaper than 97.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.32
MORLD.OL Per share dataMORLD.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

MORLD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MORLD's earnings are expected to grow with 39.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y64.89%
EPS Next 3Y39.99%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MORLD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MORELD ASA

OSL:MORLD (10/6/2025, 7:00:00 PM)

18

-0.06 (-0.33%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-27 2025-11-27
Inst Owners22.56%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap3.23B
Analysts86
Price Target22.44 (24.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)184.62%
Min EPS beat(2)-12.31%
Max EPS beat(2)381.55%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)14.85%
Min Revenue beat(2)3.87%
Max Revenue beat(2)25.83%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)15.79%
PT rev (3m)15.79%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.2
P/S 0.45
P/FCF N/A
P/OCF N/A
P/B 3.69
P/tB N/A
EV/EBITDA 3.32
EPS(TTM)-4.04
EYN/A
EPS(NY)2.9
Fwd EY16.14%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS39.68
BVpS4.88
TBVpS-2.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.35%
ROE -81.15%
ROCE 13.95%
ROIC 10.74%
ROICexc 15.14%
ROICexgc 35.04%
OM 6.38%
PM (TTM) N/A
GM 56.69%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity 2.37
Debt/FCF N/A
Debt/EBITDA 1.36
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1
Quick Ratio 0.98
Altman-Z 1.74
F-ScoreN/A
WACC7.92%
ROIC/WACC1.36
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1075.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y174.7%
EPS Next 2Y64.89%
EPS Next 3Y39.99%
EPS Next 5YN/A
Revenue 1Y (TTM)665749.35%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year42.2%
Revenue Next 2Y16.33%
Revenue Next 3Y11.57%
Revenue Next 5YN/A
EBIT growth 1Y1792.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year156.29%
EBIT Next 3Y32.73%
EBIT Next 5YN/A
FCF growth 1Y1200420%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1252060%
OCF growth 3YN/A
OCF growth 5YN/A